MedPath
FDA Product

budesonide

Product approved by U.S. Food and Drug Administration (US)

Basic Information

budesonide

68682-658

Regulatory Information

68682-658

NDA205613

C73594

October 1, 2021

USA

These highlights do not include all the information needed to use BUDESONIDE RECTAL FOAM safely and effectively. See full prescribing information for BUDESONIDE RECTAL FOAM.BUDESONIDE rectal foamInitial U.S. Approval: 1997

HUMAN PRESCRIPTION DRUG LABEL

4

Company Information

832011691

Active Ingredients

BUDESONIDE

Quantity: 28 mg in 1 1

Code: Q3OKS62Q6X

Class Code: ACTIB

Inactive Ingredients

CETYL ALCOHOL

Code: 936JST6JCN

Class Code: IACT

CITRIC ACID MONOHYDRATE

Code: 2968PHW8QP

Class Code: IACT

CETOSTEARYL ALCOHOL

Code: 2DMT128M1S

Class Code: IACT

POLYSORBATE 60

Code: CAL22UVI4M

Class Code: IACT

STEARETH-10

Code: FD0913P475

Class Code: IACT

PROPYLENE GLYCOL

Code: 6DC9Q167V3

Class Code: IACT

WATER

Code: 059QF0KO0R

Class Code: IACT

BUTANE

Code: 6LV4FOR43R

Class Code: IACT

ISOBUTANE

Code: BXR49TP611

Class Code: IACT

EDETATE DISODIUM

Code: 7FLD91C86K

Class Code: IACT

PROPANE

Code: T75W9911L6

Class Code: IACT

Active Moieties

BUDESONIDE

Code: Q3OKS62Q6X

© Copyright 2025. All Rights Reserved by MedPath